James M. Backes

1.3k total citations
43 papers, 923 citations indexed

About

James M. Backes is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, James M. Backes has authored 43 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 13 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Economics and Econometrics. Recurrent topics in James M. Backes's work include Lipoproteins and Cardiovascular Health (30 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). James M. Backes is often cited by papers focused on Lipoproteins and Cardiovascular Health (30 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). James M. Backes collaborates with scholars based in United States. James M. Backes's co-authors include Patrick M. Moriarty, Cheryl Gibson, Janelle F. Ruisinger, Patricia Howard, Daniel E. Hilleman, Deborah Anzalone, Paul M. Thompson, César Venero, Theresa I. Shireman and Amanda Reichard and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Cardiology and Alzheimer s & Dementia.

In The Last Decade

James M. Backes

41 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James M. Backes United States	17	482	227	148	132	127	43	923
Elena Olmastroni Italy	13	335 0.7×	219 1.0×	99 0.7×	137 1.0×	170 1.3×	48	995
Ripple Talati United States	14	270 0.6×	165 0.7×	93 0.6×	95 0.7×	94 0.7×	25	801
Rafael Bitzur Israel	13	228 0.5×	244 1.1×	91 0.6×	141 1.1×	167 1.3×	30	712
Tu T. Nguyen United States	18	733 1.5×	492 2.2×	168 1.1×	103 0.8×	207 1.6×	30	1.3k
Sephy Philip United States	18	569 1.2×	557 2.5×	295 2.0×	125 0.9×	120 0.9×	57	1.1k
Oliver Weingärtner Germany	23	913 1.9×	296 1.3×	188 1.3×	100 0.8×	368 2.9×	65	1.5k
Eliscer Guzman United States	17	374 0.8×	337 1.5×	45 0.3×	183 1.4×	194 1.5×	28	1.0k
Chen Shapira Israel	15	236 0.5×	172 0.8×	137 0.9×	83 0.6×	137 1.1×	26	978
G. Ferns United Kingdom	16	252 0.5×	349 1.5×	145 1.0×	132 1.0×	136 1.1×	40	975
Giovanni Battista Vigna Italy	21	806 1.7×	479 2.1×	97 0.7×	127 1.0×	202 1.6×	55	1.5k

Countries citing papers authored by James M. Backes

Since Specialization

Citations

This map shows the geographic impact of James M. Backes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Backes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Backes more than expected).

Fields of papers citing papers by James M. Backes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Backes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Backes. The network helps show where James M. Backes may publish in the future.

Co-authorship network of co-authors of James M. Backes

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Backes. A scholar is included among the top collaborators of James M. Backes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Backes. James M. Backes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hilleman, Daniel E., James L. Vacek, & James M. Backes. (2024). Elevated Lp(a): Guidance for Identifying and Managing Patients. Southern Medical Journal. 117(4). 208–213. 1 indexed citations

Backes, James M. & Daniel E. Hilleman. (2024). A Clinicians Guide to Recommending Common Cholesterol-Lowering Dietary Supplements. American Journal of Cardiovascular Drugs. 24(6). 719–728. 2 indexed citations

Hilleman, Daniel E., et al.. (2023). Atherosclerotic Cardiovascular Disease in Women: Providing Protection With Lipid-altering Agents. Clinical Therapeutics. 45(11). 1127–1136. 3 indexed citations

Gibson, Cheryl, et al.. (2022). Identifying Patient Perceptions and Attitudes Regarding statin-associated Diabetes Mellitus: A mixed-methods Study. Future Cardiology. 18(10). 817–828. 2 indexed citations

Backes, James M., Brittany L. Melton, Janelle F. Ruisinger, Crystal Burkhardt, & Patrick M. Moriarty. (2018). Comparing patients’ prescribed, self-reported, and actual intake of supplemental eicosapentaenoic acid + docosahexaenoic acid. Journal of clinical lipidology. 13(1). 170–175.

Backes, James M., et al.. (2016). Statin-Associated Diabetes Mellitus: Review and Clinical Guide. Southern Medical Journal. 109(3). 167–173. 21 indexed citations

Backes, James M., et al.. (2016). The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia. Lipids in Health and Disease. 15(1). 118–118. 141 indexed citations

Backes, James M., Thomas Dayspring, Daniel M Hoefner, & Patrick M. Moriarty. (2015). Hypertriglyceridaemia unresponsive to multiple treatments. BMJ Case Reports. 2015. bcr2015210788–bcr2015210788. 4 indexed citations

Ruisinger, Janelle F., Cheryl Gibson, James M. Backes, et al.. (2014). Statins and almonds to lower lipoproteins (the STALL Study). Journal of clinical lipidology. 9(1). 58–64. 35 indexed citations

10.

Backes, James M. & Patricia Howard. (2014). Krill Oil for Cardiovascular Risk Prevention: Is it for Real?. Hospital Pharmacy. 49(10). 907–912. 12 indexed citations

11.

Moriarty, Patrick M., et al.. (2012). Apple pectin for the reduction of niacin-induced flushing. Journal of clinical lipidology. 7(2). 140–146. 7 indexed citations

12.

Backes, James M., et al.. (2012). Pseudohypertriglyceridemia: Two cases of probable glycerol kinase deficiency. Journal of clinical lipidology. 6(5). 469–473. 12 indexed citations

13.

Backes, James M., Cheryl Gibson, Janelle F. Ruisinger, & Patrick M. Moriarty. (2011). The high-dose rosuvastatin once weekly study (The HD-ROWS). Journal of clinical lipidology. 6(4). 362–367. 10 indexed citations

14.

Backes, James M., Robert J. Padley, & Patrick M. Moriarty. (2011). Important Considerations for Treatment with Dietary Supplement versus Prescription Niacin Products. Postgraduate Medicine. 123(2). 70–83. 11 indexed citations

15.

Moriarty, Patrick M., James P. Luyendyk, Cheryl Gibson, & James M. Backes. (2010). Effect of Low-Density Lipoprotein Apheresis on Plasma Levels of Apolipoprotein E4. The American Journal of Cardiology. 105(11). 1585–1587. 11 indexed citations

16.

Shireman, Theresa I., Amanda Reichard, Niaman Nazir, James M. Backes, & K. Allen Greiner. (2009). Quality of diabetes care for adults with developmental disabilities. Disability and health journal. 3(3). 179–185. 50 indexed citations

17.

Ruisinger, Janelle F., James M. Backes, Cheryl Gibson, & Patrick M. Moriarty. (2008). Once-a-Week Rosuvastatin (2.5 to 20 mg) in Patients With a Previous Statin Intolerance. The American Journal of Cardiology. 103(3). 393–394. 53 indexed citations

18.

Backes, James M., Patrick M. Moriarty, Janelle F. Ruisinger, & Cheryl Gibson. (2007). Effects of Once Weekly Rosuvastatin Among Patients With a Prior Statin Intolerance††Conflicts of interest: Dr. Backes is with the Speakers Bureau of Abbott Labs, Abbott Park, Illinois. Dr. Moriarty receives research funding from and is a consultant for B Braun. Dr. Moriarty has also been a consultant for sanofi aventis, Bridgewater, New Jersey, and Reliant Pharmaceuticals, Liberty Corner, New Jersey; with the Speakers Bureaus of Astra Zeneca, Wilmington, Delaware; Abbott Labs, Abbott Park, Illinois; Merck/Schering-Plough, Whitehouse Station, New Jersey, and Takeda Pharmaceuticals, Deerfield, Illinois; and has performed contracted research for Kos Pharmaceuticals, Abbott Park, Illinois; sanofi aventis; Novartis, Basel, Switzerland, HELP Inc., Dover, Delaware; and Kaneka, NY, NY.. The American Journal of Cardiology. 100(3). 554–555. 40 indexed citations

19.

Backes, James M., Cheryl Gibson, & Patricia Howard. (2005). Optimal Lipid Modification: The Rationale for Combination Therapy. SHILAP Revista de lepidopterología. 1 indexed citations

20.

Backes, James M., Cheryl Gibson, & Patricia Howard. (2005). Optimal lipid modification: the rationale for combination therapy. Vascular Health and Risk Management. 1(4). 317–331. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact